Renergen (JSE:REN) ROCE % : -5.79% (As of Aug. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Renergen ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Renergen's annualized ROCE % for the quarter that ended in Aug. 2024 was -5.79%.

Renergen ROCE % Historical Data

The historical data trend for Renergen's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen ROCE % Chart

Renergen Annual Data

Trend

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Feb25

ROCE %

Get a 7-Day Free Trial

-6.81

-4.14

-2.28

-6.47

Renergen Semi-Annual Data
	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24
ROCE %	Get a 7-Day Free Trial												-4.31	-0.57	-6.66	-7.13	-5.79

Renergen ROCE % Calculation

Renergen's annualized ROCE % for the fiscal year that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Feb. 2024 )		(A: Feb. 2023 )		(A: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Feb. 2024 )		(A: Feb. 2023 )		(A: Feb. 2024 )
	=	-124.244	/	( ( (1900.881 - 200.354)	+	(2709.127 - 571.557) )	/ 2 )
	=	-124.244	/	( (1700.527	+	2137.57)	/ 2 )
	=	-124.244	/	1919.0485
	=	-6.47 %

Renergen's ROCE % of for the quarter that ended in Aug. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Aug. 2024 )		(Q: Feb. 2024 )		(Q: Aug. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Aug. 2024 )		(Q: Feb. 2024 )		(Q: Aug. 2024 )
	=	-119.352	/	( ( (2709.127 - 571.557)	+	(2455.384 - 469.63) )	/ 2 )
	=	-119.352	/	( ( 2137.57	+	1985.754 )	/ 2 )
	=	-119.352	/	2061.662
	=	-5.79 %

(1) Note: The EBIT data used here is two times the semi-annual (Aug. 2024) EBIT data.

Renergen (JSE:REN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Renergen ROCE % Related Terms

Thank you for viewing the detailed overview of Renergen's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renergen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (JSE:REN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

RGNNF:USA 9960:Germany RLT:Australia

Address

25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196

Website

https://www.renergen.co.za

Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.